Most women believe that having their annual mammograms and clinical breast exams is enough to catch cancer if it develops.
But University of Cincinnati (UC) breast cancer experts counsel that paying attention to even minor changes in breast appearance could save your life if you get a rare form of the disease known as “inflammatory” breast cancer. Unlike most other forms of breast cancer, they say, this disease is undetectable on a mammogram and doesn’t start as a lump.
“Inflammatory breast cancer starts as a tissue thickening or redness, versus a lump that can be felt,” explains Jennifer Manders, MD, assistant professor and breast surgeon at the UC, “so it often goes undetected until the disease has spread to the lymph nodes and possibly to other areas of the body.”
There are two primary types of breast cancer: noninvasive, which is localized to one place, and invasive, which can spread to other parts of the body. Inflammatory breast cancer is a very aggressive form of invasive cancer caused by a build-up of breast cancer cells that block the lymphatic vessels.
The body’s lymphatic system produces and stores cells to fight off infection and disease. Breast lymphatics, tiny channels similar to blood vessels, transport fluid from the breast tissue to the lymph node glands in the underarm, which in turn help to fight infection and disease. Inflammatory breast cancer cells enter directly into the lymphatic channels within the skin of the breast, allowing the disease to spread more quickly to other parts of the body.
Although scientists estimate that the disease represents only 1 to 5 percent of all breast cancers, it is one of the most difficult types to treat because it is often diagnosed in an advanced stage.
“There is a lack of awareness about this disease,” says Manders, “so women often dismiss the warning signs of inflammatory breast cancer because it’s not obvious that something is wrong.”
Those warning signs include painless skin discoloration or redness (similar to a bug bite), rapid increase in breast size, an inverted nipple, and enlarged lymph nodes in the underarms or neck.
“Every woman should be familiar with the way her breasts look and feel normally,” adds Zeina Nahleh, MD, a medical oncologist and assistant professor at UC. “That way, she can quickly identify suspicious changes and have them examined immediately by a physician.”
Treatment for inflammatory breast cancer typically involves chemotherapy first, to halt the spread of cancer, followed by surgery to remove the lymph nodes and breast tissue and chest radiation to kill any remaining cancer cells.
“What’s important is that women recognize the warning signs before the disease becomes untreatable,” adds Nahleh.
For more information on inflammatory breast cancer, visit
http://www.netwellness.org , a collaborative health-information Web site staffed by Ohio physicians, nurses and allied health professionals.
Source: University of Cincinnati
Related stories:
Mechanisms of cardiovascular disease and cancer give clues to new therapies
Cardiovascular conditions leading to heart attacks and strokes are treated quite separately from common cancers of the prostate, breast or lung, but now turn out to involve some of the same critical mechanisms at the molecular level. This in turn provides clues to more effective therapies for both cancer and cardiovascular diseases, but requires researchers in these distinct fields to come together. The seeds were sown for closer cooperation between these two groups at a recent workshop organised by the European Science Foundation (ESF), which also highlighted the striking progress already made in understanding key common mechanisms underlying both disease categories.
Scientist to bare his DNA
Here's some personal information about Misha Angrist: His blood pressure is 104 over 65. He weighs 173 pounds, has fought anxiety and depression and is very allergic to cats.
European patent office restores breast cancer gene patent
The European Patent Office on Wednesday restored on appeal a controversial patent for a breast cancer gene that had been withdrawn from a US biotech firm, but granting it in a more restricted form than before.
Study identifies causes of bone loss in breast cancer survivors
Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss.
Researchers find clue to stopping breast-cancer metastasis
If scientists knew exactly what a breast cancer cell needs to spread, then they could stop the most deadly part of the disease: metastasis. New research from the University of North Carolina at Chapel Hill School of Medicine takes a step in that direction.
Breast cancer common among women with family history but without BRCA1 or BRCA2
New data presented at the American Association for Cancer Research's Seventh Annual International Frontiers in Cancer Prevention Research meeting outlines new data, which assesses breast cancer risk among women with a strong family history of breast cancer, but without a BRCA1 or BRCA2 mutation. This may facilitate earlier detection and prevention among high-risk women.
Genetic risk factors may tailor prostate cancer screening approaches
Men with a family history of prostate cancer and African-American men are particularly susceptible to the disease, with a twofold to sevenfold increased risk. Assessing risk in these populations has been difficult.
Why only some former smokers develop lung cancer
Canadian researchers are trying to answer why some smokers develop lung cancer while others remain disease free, despite similar lifestyle changes.